Skip to content

Two Years Maintenance of Structured Group Self-management Education in Type 2 Diabetes : a Randomized Controlled Trial

Multicenter Randomized Trial of Structured Educational Intervention at the Community Level in Insufficiently Controlled Patients With Type 2 Diabetes in Reunion Island

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01425866
Acronym
ERMIES
Enrollment
132
Registered
2011-08-30
Start date
2011-10-31
Completion date
2016-09-30
Last updated
2024-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes

Keywords

Diabetes Mellitus, Diabetes Mellitus, Type 2, Structured self-management education, Therapeutic patient education, Lifestyle changes, Self-management Blood glucose, Empowerment, Adult learning, Socio-constructivism, Health management network, Reunion island

Brief summary

Type 2 diabetes has a growing impact on populations and public health worldwide. Clinical trials have clearly demonstrated that a better control of blood glucose level and of other risk factors is efficient in preventing or retarding the complications of the disease. On Reunion island, Type 2 diabetes is present in 18% of population aged 30 or older with a high level of socio-economic deprivation. The hypothesis of the ERMIES study is that a structured group self-management education maintained at the community level for 2 years in patients with insufficiently controlled type 2 diabetes has better metabolic results (as attested by improvement in HbA1c level) at 2 yrs, compared to an initial short term (\< 3 months) self-management program, based on the same theoretical basis and framework (learning nests empowerment). A total of 240 adults living in Reunion Island, with type 2 diabetes mellitus with HbA1c ≥ 7.5% on a stable treatment for at least 3 months will be randomly allocated to 2 intervention arms: either a short term (\< 3 months) program (1 to 7 thematic 2-hr long sessions depending on individual assessment), or a long term program including the same initial program as 1st arm, but with group self management education sessions, maintained for 2 years (4-monthly assessment, empowerment, and contextual action planning; facultative additional specific thematic sessions being delivered if needed). Medical visits will be held quarterly for the recording of outcome measures (HbA1c, blood pressure, anthropometrics, tobacco consumption, diabetes complications) and yearly for blood glucose, lipids, micro-albuminuria or proteinuria, creatinine clearance, diet and exercise (questionnaires), treatment recording, quality of life, self-efficacy, anxiety and depression scales, and social support.

Detailed description

Randomised clinical trial comparing 2 parallel arms of educational intervention with the hypothesis of the superiority of a 2-year maintenance of a structured, theoretically-based, educational follow-up. All subjects of both arms will beneficiate from an initial structured educational program (\< 3-months). Subjects, educators, and investigators will be unaware of the group allocation during this initial round. Then the intervention arm will undergo a 2 years self management educational follow-up program. Randomisation will be stratified on 2 factors : centres (5 strata) and anti diabetic treatment (2 strata: insulin-treated or not). All group sessions (3-10 subjects, 2 hr-long, one assessment group session and 6 facultative additional specific sessions for each round \[initial in both arms or follow-up in the intervention arm\], as needed and planned during the first) will be held at the community level, as closer as possible to the subjects' residence. Educators are specifically trained and the educational sessions are structured and coordinated in the framing and organisational supervision of the health management network ReuCARE in Reunion island. Subjects of both arms will continue quarterly to attend at the outpatient clinic of the centre. This trial is associated to a qualitative ethno-sociological study on a sample of 30-40 subjects, with in-depth interviews and ethnographic observation of group sessions, with the specific aim of describing the learning processes, coping, health and functional literacy, social and contextual issues.

Interventions

BEHAVIORALStructured self-management group education during 2 years

After an initial intensive group education, four-monthly follow-up self-management group education sessions for 2 years. Each session is based on empowerment, socio-constructivism, social learning theory: personalized assessment (BG and risk factors, actions: realized, planned, achieved (or not), cognitive work, analysis of individual and social context and environment (facilitators, obstacles) then action planning. Specific additional sessions can be scheduled (food management, diabetes treatment and hypoglycemia, exercise, self monitoring of BG, insulin dosage, foot care). Sessions are framed, and structured, with patient booklet support. Sessions are delivered at the community level, by trained registered nurses, under the coordination of the health management network Reucare.

Sponsors

Ministry of Health, France
CollaboratorOTHER_GOV
Centre Hospitalier Universitaire de la Réunion
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Type 2 diabetes * HbA1c ≥ 7,5% more than 3 months * Adults * ≥ 1 year ADO and/or insulin and/or GLP-1 analog * antidiabetic treatment unchanged since 3 months (no change of treatment in the last 3 months, except for insulin dosage) * Living in Reunion Island * Affiliated to French national health insurance * Signed informed consent

Exclusion criteria

* Treatment or associated conditions that would influence glycemic control, such as corticotherapy, cancer, inflammatory chronic diseases * Hospitalisation linked to diabetes \< 3 months * Structured patient education in the past 3 months * Severe diabetes complications (e.g. ischemic or proliferative retinopathy, severe renal failure (clearance \< 15 ml/min), acute ischemic heart disease (\< 6 months, foot lesion) * Pregnancy (on-going or planned during the study) * Evolutive cancer * Physical or cognitive heavy handicap * Concomitant participation to a therapeutic trial

Design outcomes

Primary

MeasureTime frame
Mean change in glycated haemoglobin (GlyHb)0 and 2 years

Secondary

MeasureTime frameDescription
change in GlyHbquarterly up to 2 yrs
Blood sugar and lipids1 and 2 yrsBlood sugar Total, HDL and LDL cholesterol, triglycerides
diabetes complications1 and 2 yrsretinopathy stages, micro-albuminuria or proteinuria, creatinine clearance, foot risk grade, ischemic heart or cerebral disease
health behaviours1 and 2 yrsphysical activity and diet (Baecke and food frequency questionnaires)
anti-diabetic therapy1 and 2 yrstype, dosage
health care process1 and 2 yrsmedical follow-up and appointments, compliance (questionnaire)
Mean change in glycated haemoglobin (GlyHb)0 and 1 year
Quality of Life1 and 2 yrsshort DQOL adapted and validated for Reunion
Change in tobacco consumptionquarterly up to 2 yrs
Change in fasting blood glucosequarterly up to 2 yrs
Change in body mass indexquarterly up to 2 yrs
Change in waist circumferencequarterly up to 2 yrs
Change in blood pressurequarterly up to 2 yrs
Psychometric scales1 and 2 yrsself-efficacy, social support, HAD (anxiety and depression)

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 25, 2026